| PICTET - JAPANESE EQUITY OPPORTUNITIES R JPY | RVI JAPÓN | 24,56% | 60,09% | 45,89% | 108,58% |
| YIS MSCI JAPAN UNIVERSAL C | RVI JAPÓN | 24,56% | · | · | · |
| ABN AMRO BOSTON TRUST WALDEN US ESG EQUITIES I USD CAP | RVI USA | 24,55% | 52,27% | 52,51% | · |
| ALLIANZ GLOBAL INTELLIGENT CITIES INCOME AT USD | MIXTO FLEXIBLE | 24,55% | 73,49% | 48,40% | · |
| GOLDMAN SACHS MULTI-MANAGER EMERGING MARKETS EQUITY PORTFOLIO P DIS USD | RVI EMERGENTES | 24,55% | 73,49% | 36,31% | 84,13% |
| SCHRODER ISF EMERGING MARKETS C DIS USD | RVI EMERGENTES | 24,55% | 74,75% | 31,20% | 92,91% |
| AMUNDI FUNDS US EQUITY RESEARCH VALUE R USD (C) | RVI USA VALOR | 24,54% | 55,33% | 54,24% | · |
| AXA WORLD FUNDS-EMERGING MARKETS RESPONSIBLE EQUITY QI F CAP EUR | RVI EMERGENTES | 24,54% | 65,29% | 26,90% | 83,86% |
| FIDELITY US QUALITY VALUE UCITS ETF USD (ACC) | RVI USA VALOR | 24,54% | · | · | · |
| FRANKLIN BIOTECHNOLOGY DISCOVERY A (ACC) USD | RVI BIOTECNOLOGÍA | 24,54% | 89,12% | 65,13% | 129,72% |
